<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34840991</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>10</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2314-7156</ISSN><JournalIssue CitedMedium="Internet"><Volume>2021</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Journal of immunology research</Title><ISOAbbreviation>J Immunol Res</ISOAbbreviation></Journal><ArticleTitle>IL-18: The Forgotten Cytokine in Dengue Immunopathogenesis.</ArticleTitle><Pagination><StartPage>8214656</StartPage><MedlinePgn>8214656</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">8214656</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1155/2021/8214656</ELocationID><Abstract><AbstractText>Dengue fever is an infection by the dengue virus (DENV) transmitted by vector mosquitoes. It causes many infections in tropical and subtropical countries every year, thus posing a severe disease threat. Cytokine storms, one condition where many proinflammatory cytokines are mass-produced, might lead to cellular dysfunction in tissue/organ failures and often facilitate severe dengue disease in patients. Interleukin- (IL-) 18, similar to IL-1<i>&#x3b2;</i>, is a proinflammatory cytokine produced during inflammation following inflammasome activation. Inflammatory stimuli, including microbial infections, damage signals, and cytokines, all induce the production of IL-18. High serum IL-18 is remarkably correlated with severely ill dengue patients; however, its possible roles have been less explored. Based on the clinical and basic findings, this review discusses the potential immunopathogenic role of IL-18 when it participates in DENV infection and dengue disease progression based on existing findings and related past studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Josephine Diony Nanda et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nanda</LastName><ForeName>Josephine Diony</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Tzong-Shiann</ForeName><Initials>TS</Initials><Identifier Source="ORCID">0000-0003-2951-6679</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pediatrics, Tainan Hospital, Ministry of Health and Welfare, Tainan 700, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Satria</LastName><ForeName>Rahmat Dani</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Pathology and Laboratory Medicine, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta 55281, Indonesia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Laboratory Installation, Dr. Sardjito Central General Hospital, Yogyakarta 55281, Indonesia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jhan</LastName><ForeName>Ming-Kai</ForeName><Initials>MK</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yung-Ting</ForeName><Initials>YT</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chiou-Feng</ForeName><Initials>CF</Initials><Identifier Source="ORCID">0000-0003-4396-6086</Identifier><AffiliationInfo><Affiliation>International Ph.D. Program in Cell Therapy and Regenerative Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 110, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Egypt</Country><MedlineTA>J Immunol Res</MedlineTA><NlmUniqueID>101627166</NlmUniqueID><ISSNLinking>2314-7156</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058847">Inflammasomes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020382">Interleukin-18</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053583">Interleukin-1beta</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000330" MajorTopicYN="N">Aedes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004199" MajorTopicYN="N">Disease Vectors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058847" MajorTopicYN="N">Inflammasomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020382" MajorTopicYN="N">Interleukin-18</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053583" MajorTopicYN="N">Interleukin-1beta</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>29</Day><Hour>6</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34840991</ArticleId><ArticleId IdType="pmc">PMC8626198</ArticleId><ArticleId IdType="doi">10.1155/2021/8214656</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. Dengue and severe dengue: World Health Organization.  2021,  https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue.</Citation></Reference><Reference><Citation>Daep C. A., Mu&#xf1;oz-Jord&#xe1;n J. L., Eugenin E. A. Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. Journal of Neurovirology . 2014;20(6):539&#x2013;560. doi: 10.1007/s13365-014-0285-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13365-014-0285-z</ArticleId><ArticleId IdType="pmc">PMC4331079</ArticleId><ArticleId IdType="pubmed">25287260</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekwudu O. M., Marquart L., Webb L., et al. Effect of serotype and strain diversity on dengue virus replication in Australian mosquito vectors. Pathogens . 2020;9(8):p. 668. doi: 10.3390/pathogens9080668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9080668</ArticleId><ArticleId IdType="pmc">PMC7460537</ArticleId><ArticleId IdType="pubmed">32824792</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E. C., Twiddy S. S. The origin, emergence and evolutionary genetics of dengue virus. Infection, Genetics and Evolution . 2003;3(1):19&#x2013;28. doi: 10.1016/S1567-1348(03)00004-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1567-1348(03)00004-2</ArticleId><ArticleId IdType="pubmed">12797969</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S., Gething P. W., Brady O. J., et al. The global distribution and burden of dengue. Nature . 2013;496(7446):504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Dengue Situation Update Number 629 . 2021.</Citation></Reference><Reference><Citation>World Health Organization ROfS-EA. Comprehensive Guideline for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. Revised and Expanded Edition . WHO Regional Office for South-East Asia; 2011.</Citation></Reference><Reference><Citation>Kalayanarooj S. Clinical manifestations and management of dengue/DHF/DSS. Trop Med Health . 2011;39(4 Suppl):83&#x2013;87. doi: 10.2149/tmh.2011-S10.</Citation><ArticleIdList><ArticleId IdType="doi">10.2149/tmh.2011-S10</ArticleId><ArticleId IdType="pmc">PMC3317599</ArticleId><ArticleId IdType="pubmed">22500140</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC. Dengue 2021.  September 2021,  https://www.cdc.gov/dengue/symptoms/index.html.</Citation></Reference><Reference><Citation>Vicente C. R., Herbinger K.-H., Fr&#xf6;schl G., Malta Romano C., de Souza Areias Cabidelle A., Cerutti Junior C. Serotype influences on dengue severity: a cross-sectional study on 485 confirmed dengue cases in Vit&#xf3;ria, Brazil. BMC Infectious Diseases . 2016;16(1):p. 320. doi: 10.1186/s12879-016-1668-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-016-1668-y</ArticleId><ArticleId IdType="pmc">PMC4938938</ArticleId><ArticleId IdType="pubmed">27393011</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng S. P., Yen C. H., Chang K., et al. Severe dengue fever outbreak in Taiwan. The American Journal of Tropical Medicine and Hygiene . 2016;94(1):193&#x2013;197. doi: 10.4269/ajtmh.15-0422.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.15-0422</ArticleId><ArticleId IdType="pmc">PMC4710429</ArticleId><ArticleId IdType="pubmed">26572871</ArticleId></ArticleIdList></Reference><Reference><Citation>Yung C.-F., Lee K.-S., Thein T.-L., et al. Dengue serotype-specific differences in clinical manifestation, laboratory parameters and risk of severe disease in adults, Singapore. The American Journal of Tropical Medicine and Hygiene . 2015;92(5):999&#x2013;1005. doi: 10.4269/ajtmh.14-0628.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.14-0628</ArticleId><ArticleId IdType="pmc">PMC4426593</ArticleId><ArticleId IdType="pubmed">25825386</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatura S. N. N., Denis D., Santoso M. S., et al. Outbreak of severe dengue associated with DENV-3 in the city of Manado, North Sulawesi, Indonesia. International Journal of Infectious Diseases . 2021;106:185&#x2013;196. doi: 10.1016/j.ijid.2021.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.03.065</ArticleId><ArticleId IdType="pubmed">33774189</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitmeyer K. C., Vaughn D. W., Watts D. M., Salas R., Villalobos I. Dengue virus structural differences that correlate with pathogenesis. Journal of Virology . 1999;73(6):4738&#x2013;4747. doi: 10.1128/JVI.73.6.4738-4747.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.6.4738-4747.1999</ArticleId><ArticleId IdType="pmc">PMC112516</ArticleId><ArticleId IdType="pubmed">10233934</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong P. M., Rico-Hesse R. Differential susceptibility of Aedes aegypti to infection by the American and Southeast Asian genotypes of dengue type 2 virus. Vector Borne and Zoonotic Diseases . 2001;1(2):159&#x2013;168. doi: 10.1089/153036601316977769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/153036601316977769</ArticleId><ArticleId IdType="pmc">PMC3057097</ArticleId><ArticleId IdType="pubmed">12680353</ArticleId></ArticleIdList></Reference><Reference><Citation>Pryor M. J., Carr J. M., Hocking H., Davidson A. D., Li P., Wright P. J. Replication of dengue virus type 2 in human monocyte-derived macrophages: comparisons of isolates and recombinant viruses with substitutions at amino acid 390 in the envelope glycoprotein. The American Journal of Tropical Medicine and Hygiene . 2001;65(5):427&#x2013;434. doi: 10.4269/ajtmh.2001.65.427.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.2001.65.427</ArticleId><ArticleId IdType="pubmed">11716094</ArticleId></ArticleIdList></Reference><Reference><Citation>Proutski V., Gritsun T. S., Gould E. A., Holmes E. C. Biological consequences of deletions within the 3&#x2009;&#x2032;-untranslated region of flaviviruses may be due to rearrangements of RNA secondary structure. Virus Research . 1999;64(2):107&#x2013;123. doi: 10.1016/S0168-1702(99)00079-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(99)00079-9</ArticleId><ArticleId IdType="pubmed">10518708</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliks S. Antibody-enhanced infection of monocytes as the pathogenetic mechanism for severe dengue illness. AIDS Research and Human Retroviruses . 1990;6(8):993&#x2013;998. doi: 10.1089/aid.1990.6.993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/aid.1990.6.993</ArticleId><ArticleId IdType="pubmed">2223245</ArticleId></ArticleIdList></Reference><Reference><Citation>Goncalvez A. P., Engle R. E., St Claire M., Purcell R. H., Lai C. J. Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proceedings of the National Academy of Sciences of the United States of America . 2007;104(22):9422&#x2013;9427. doi: 10.1073/pnas.0703498104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0703498104</ArticleId><ArticleId IdType="pmc">PMC1868655</ArticleId><ArticleId IdType="pubmed">17517625</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor A., Foo S. S., Bruzzone R., Dinh L. V., King N. J., Mahalingam S. Fc receptors in antibody-dependent enhancement of viral infections. Immunological Reviews . 2015;268(1):340&#x2013;364. doi: 10.1111/imr.12367.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12367</ArticleId><ArticleId IdType="pmc">PMC7165974</ArticleId><ArticleId IdType="pubmed">26497532</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn D. W., Green S., Kalayanarooj S., et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. The Journal of Infectious Diseases . 2000;181(1):2&#x2013;9. doi: 10.1086/315215.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/315215</ArticleId><ArticleId IdType="pubmed">10608744</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochel T. J., Watts D. M., Halstead S. B., et al. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. The Lancet . 2002;360(9329):310&#x2013;312. doi: 10.1016/S0140-6736(02)09522-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)09522-3</ArticleId><ArticleId IdType="pubmed">12147378</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Roche R., Blanc H., Border&#xed;a A. V., et al. Increasing clinical severity during a dengue virus type 3 Cuban epidemic: deep sequencing of evolving viral populations. Journal of Virology . 2016;90(9):4320&#x2013;4333. doi: 10.1128/JVI.02647-15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02647-15</ArticleId><ArticleId IdType="pmc">PMC4836355</ArticleId><ArticleId IdType="pubmed">26889031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hapuarachchi H. C., Koo C., Rajarethinam J., et al. Epidemic resurgence of dengue fever in Singapore in 2013-2014: a virological and entomological perspective. BMC Infectious Diseases . 2016;16(1):p. 300. doi: 10.1186/s12879-016-1606-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-016-1606-z</ArticleId><ArticleId IdType="pmc">PMC4912763</ArticleId><ArticleId IdType="pubmed">27316694</ArticleId></ArticleIdList></Reference><Reference><Citation>Fajgenbaum D. C., June C. H. Cytokine Storm. New England Journal of Medicine . 2020;383(23):2255&#x2013;2273. doi: 10.1056/NEJMra2026131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra2026131</ArticleId><ArticleId IdType="pmc">PMC7727315</ArticleId><ArticleId IdType="pubmed">33264547</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A., Mathew A., Rothman A. L. Immune-mediated cytokine storm and its role in severe dengue. Seminars in Immunopathology . 2017;39(5):563&#x2013;574. doi: 10.1007/s00281-017-0625-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0625-1</ArticleId><ArticleId IdType="pmc">PMC5496927</ArticleId><ArticleId IdType="pubmed">28401256</ArticleId></ArticleIdList></Reference><Reference><Citation>Maucourant C., Queiroz G. A. N., Samri A., Grassi M. F. R., Yssel H., Vieillard V. Zika virus in the eye of the cytokine storm. European Cytokine Network . 2019;30(3):74&#x2013;81. doi: 10.1684/ecn.2019.0433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/ecn.2019.0433</ArticleId><ArticleId IdType="pubmed">31957701</ArticleId></ArticleIdList></Reference><Reference><Citation>Leis A. A., Grill M. F., Goodman B. P., et al. Tumor necrosis factor-alpha signaling may contribute to chronic West Nile virus post-infectious proinflammatory state. Frontiers in Medicine . 2020;7(164) doi: 10.3389/fmed.2020.00164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00164</ArticleId><ArticleId IdType="pmc">PMC7203783</ArticleId><ArticleId IdType="pubmed">32426358</ArticleId></ArticleIdList></Reference><Reference><Citation>ter Meulen J., Sakho M., Koulemou K., et al. Activation of the cytokine network and unfavorable outcome in patients with yellow fever. The Journal of Infectious Diseases . 2004;190(10):1821&#x2013;1827. doi: 10.1086/425016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425016</ArticleId><ArticleId IdType="pubmed">15499539</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter P. M., Dung N. M., Loan H. T., et al. Proinflammatory cytokines and chemokines in humans with Japanese encephalitis. The Journal of Infectious Diseases . 2004;190(9):1618&#x2013;1626. doi: 10.1086/423328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/423328</ArticleId><ArticleId IdType="pubmed">15478067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T. H., Nguyen T. H., Vu T. T., et al. Corticosteroids for dengue - why don&#x2019;t they work? PLoS Neglected Tropical Diseases . 2013;7(12, article e2592) doi: 10.1371/journal.pntd.0002592.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0002592</ArticleId><ArticleId IdType="pmc">PMC3861232</ArticleId><ArticleId IdType="pubmed">24349598</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava G., Valenzuela Leon P. C., Calvo E. Inflammasome fuels dengue severity. Frontiers in Cellular and Infection Microbiology . 2020;10:p. 489. doi: 10.3389/fcimb.2020.00489.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00489</ArticleId><ArticleId IdType="pmc">PMC7511630</ArticleId><ArticleId IdType="pubmed">33014899</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava G., Visoso-Carvajal G., Garcia-Cordero J., et al. Dengue virus serotype 2 and its non-structural proteins 2A and 2B activate NLRP3 inflammasome. Frontiers in Immunology . 2020;11:p. 352. doi: 10.3389/fimmu.2020.00352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00352</ArticleId><ArticleId IdType="pmc">PMC7076137</ArticleId><ArticleId IdType="pubmed">32210961</ArticleId></ArticleIdList></Reference><Reference><Citation>Harijith A., Ebenezer D. L., Natarajan V. Reactive oxygen species at the crossroads of inflammasome and inflammation. Frontiers in Physiology . 2014;5:p. 352. doi: 10.3389/fphys.2014.00352.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2014.00352</ArticleId><ArticleId IdType="pmc">PMC4179323</ArticleId><ArticleId IdType="pubmed">25324778</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D., Peri S., Steel C., et al. Cellular oxidative stress response controls the antiviral and apoptotic programs in dengue virus-infected dendritic cells. PLoS Pathogens . 2014;10(12, article e1004566-e) doi: 10.1371/journal.ppat.1004566.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004566</ArticleId><ArticleId IdType="pmc">PMC4270780</ArticleId><ArticleId IdType="pubmed">25521078</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W. H., Lin C. Y., Chang K., et al. A clinical and epidemiological survey of the largest dengue outbreak in Southern Taiwan in 2015. International Journal of Infectious Diseases . 2019;88:88&#x2013;99. doi: 10.1016/j.ijid.2019.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2019.09.007</ArticleId><ArticleId IdType="pubmed">31521850</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui L., Lee Y. H., Thein T. L., et al. Serum metabolomics reveals serotonin as a predictor of severe dengue in the early phase of dengue fever. PLoS Neglected Tropical Diseases . 2016;10(4, article e0004607) doi: 10.1371/journal.pntd.0004607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004607</ArticleId><ArticleId IdType="pmc">PMC4824427</ArticleId><ArticleId IdType="pubmed">27055163</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra G., Mallik S., Saha B., Mukhopadhyay S. Assessment of chemokine and cytokine signatures in patients with dengue infection: a hospital-based study in Kolkata, India. Acta Tropica . 2019;190:73&#x2013;79. doi: 10.1016/j.actatropica.2018.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actatropica.2018.10.017</ArticleId><ArticleId IdType="pubmed">30395811</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuczera D., Assolini J. P., Tomiotto-Pellissier F., Pavanelli W. R., Silveira G. F. Highlights for dengue immunopathogenesis: antibody-dependent enhancement, cytokine storm, and beyond. Journal of Interferon &amp; Cytokine Research . 2018;38(2):69&#x2013;80. doi: 10.1089/jir.2017.0037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2017.0037</ArticleId><ArticleId IdType="pubmed">29443656</ArticleId></ArticleIdList></Reference><Reference><Citation>Manh D. H., Weiss L. N., Thuong N. V., et al. Kinetics of CD4+ T helper and CD8+ effector T cell responses in acute dengue patients. Frontiers in Immunology . 2020;11(1980) doi: 10.3389/fimmu.2020.01980.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.01980</ArticleId><ArticleId IdType="pmc">PMC7542683</ArticleId><ArticleId IdType="pubmed">33072068</ArticleId></ArticleIdList></Reference><Reference><Citation>Okamura H., Tsutsui H., Komatsu T., et al. Cloning of a new cytokine that induces IFN-&#x3b3; production by T cells. Nature . 1995;378(6552):88&#x2013;91. doi: 10.1038/378088a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/378088a0</ArticleId><ArticleId IdType="pubmed">7477296</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura K., Okamura H., Nagata K., Komatsu T., Tamura T. Purification of a factor which provides a costimulatory signal for gamma interferon production. Infection and Immunity . 1993;61(1):64&#x2013;70. doi: 10.1128/iai.61.1.64-70.1993.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/iai.61.1.64-70.1993</ArticleId><ArticleId IdType="pmc">PMC302688</ArticleId><ArticleId IdType="pubmed">8093360</ArticleId></ArticleIdList></Reference><Reference><Citation>Fields J. K., G&#xfc;nther S., Sundberg E. J. Structural basis of IL-1 family cytokine signaling. Frontiers in Immunology . 2019;10(1412) doi: 10.3389/fimmu.2019.01412.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01412</ArticleId><ArticleId IdType="pmc">PMC6596353</ArticleId><ArticleId IdType="pubmed">31281320</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll H. P., Paunovi&#x107; V., Gadina M. Signalling, inflammation and arthritis: crossed signals: the role of interleukin-15 and -18 in autoimmunity. Rheumatology . 2008;47(9):1269&#x2013;1277. doi: 10.1093/rheumatology/ken257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken257</ArticleId><ArticleId IdType="pubmed">18621751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasuda K., Nakanishi K., Tsutsui H. Interleukin-18 in health and disease. International Journal of Molecular Sciences . 2019;20(3):p. 649. doi: 10.3390/ijms20030649.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20030649</ArticleId><ArticleId IdType="pmc">PMC6387150</ArticleId><ArticleId IdType="pubmed">30717382</ArticleId></ArticleIdList></Reference><Reference><Citation>Udagawa N., Horwood N. J., Elliott J., et al. Interleukin-18 (interferon-&#x3b3;&#x2013;inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-&#x3b3; to inhibit osteoclast formation. The Journal of Experimental Medicine . 1997;185(6):1005&#x2013;1012. doi: 10.1084/jem.185.6.1005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.185.6.1005</ArticleId><ArticleId IdType="pmc">PMC2196233</ArticleId><ArticleId IdType="pubmed">9091574</ArticleId></ArticleIdList></Reference><Reference><Citation>Koizumi H., Sato-Matsumura K. C., Nakamura H., et al. Distribution of IL-18 and IL-18 receptor in human skin: various forms of IL-18 are produced in keratinocytes. Archives of Dermatological Research . 2001;293(7):325&#x2013;333. doi: 10.1007/s004030100237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004030100237</ArticleId><ArticleId IdType="pubmed">11550805</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmkvist P., Roepstorff K., Uronen-Hansson H., et al. A major population of mucosal memory CD4+ T cells, coexpressing IL-18R&#x3b1; and DR3, display innate lymphocyte functionality. Mucosal Immunology . 2015;8(3):545&#x2013;558. doi: 10.1038/mi.2014.87.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2014.87</ArticleId><ArticleId IdType="pmc">PMC4424383</ArticleId><ArticleId IdType="pubmed">25269704</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoll S., Jonuleit H., Schmitt E., et al. Production of functional IL-18 by different subtypes of murine and human dendritic cells (DC): DC-derived IL-18 enhances IL-12-dependent Th1 development. European Journal of Immunology . 1998;28(10):3231&#x2013;3239. doi: 10.1002/(SICI)1521-4141(199810)28:10&lt;3231::AID-IMMU3231&gt;3.0.CO;2-Q.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1521-4141(199810)28:10&lt;3231::AID-IMMU3231&gt;3.0.CO;2-Q</ArticleId><ArticleId IdType="pubmed">9808192</ArticleId></ArticleIdList></Reference><Reference><Citation>Brossart P., Gr&#xfc;nebach F., Stuhler G., et al. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood . 1998;92(11):4238&#x2013;4247. doi: 10.1182/blood.V92.11.4238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V92.11.4238</ArticleId><ArticleId IdType="pubmed">9834229</ArticleId></ArticleIdList></Reference><Reference><Citation>Grandjean-Laquerriere A., Laquerriere P., Laurent-Maquin D., Guenounou M., Phillips T. M. The effect of the physical characteristics of hydroxyapatite particles on human monocytes IL-18 production in vitro. Biomaterials . 2004;25(28):5921&#x2013;5927. doi: 10.1016/j.biomaterials.2004.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2004.02.003</ArticleId><ArticleId IdType="pubmed">15183606</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Y., Kuida K., Tsutsui H., et al. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science . 1997;275(5297):206&#x2013;209. doi: 10.1126/science.275.5297.206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.275.5297.206</ArticleId><ArticleId IdType="pubmed">8999548</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto T., Takeda K., Tanaka T., et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-&#x3b3; production. The Journal of Immunology . 1998;161(7):p. 3400.</Citation><ArticleIdList><ArticleId IdType="pubmed">9759857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kohno K., Kataoka J., Ohtsuki T., et al. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12. The Journal of Immunology . 1997;158(4):1541&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pubmed">9029088</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello C. A., Fantuzzi G. Interleukin-18 and host defense against infection. The Journal of Infectious Diseases . 2003;187(Suppl 2):S370&#x2013;S384. doi: 10.1086/374751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/374751</ArticleId><ArticleId IdType="pubmed">12792854</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Lamine Mbow M., Sun L., et al. Induction of dendritic cell maturation by IL-18. Cellular Immunology . 2004;227(2):103&#x2013;108. doi: 10.1016/j.cellimm.2004.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellimm.2004.02.002</ArticleId><ArticleId IdType="pubmed">15135292</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss E. S., Girard-Guyonvarc&#x2019;h C., Holzinger D., et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood . 2018;131(13):1442&#x2013;1455. doi: 10.1182/blood-2017-12-820852.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-12-820852</ArticleId><ArticleId IdType="pmc">PMC5877443</ArticleId><ArticleId IdType="pubmed">29326099</ArticleId></ArticleIdList></Reference><Reference><Citation>Santarlasci V., Cosmi L., Maggi L., Liotta F., Annunziato F. IL-1 and T helper immune responses. Frontiers in Immunology . 2013;4(182) doi: 10.3389/fimmu.2013.00182.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2013.00182</ArticleId><ArticleId IdType="pmc">PMC3711056</ArticleId><ArticleId IdType="pubmed">23874332</ArticleId></ArticleIdList></Reference><Reference><Citation>Niu J., Wu S., Chen M., et al. Hyperactivation of the NLRP3 inflammasome protects mice against influenza A virus infection via IL-1&#x3b2; mediated neutrophil recruitment. Cytokine . 2019;120:115&#x2013;124. doi: 10.1016/j.cyto.2019.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2019.04.019</ArticleId><ArticleId IdType="pubmed">31055218</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A. C., Gomes-Neto J. F., Barbosa C. D., et al. Crucial role for T cell-intrinsic IL-18R-MyD88 signaling in cognate immune response to intracellular parasite infection. eLife . 2017;6 doi: 10.7554/eLife.30883.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30883</ArticleId><ArticleId IdType="pmc">PMC5629024</ArticleId><ArticleId IdType="pubmed">28895840</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsutsumi N., Kimura T., Arita K., et al. The structural basis for receptor recognition of human interleukin-18. Nature Communications . 2014;5(1):p. 5340. doi: 10.1038/ncomms6340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6340</ArticleId><ArticleId IdType="pmc">PMC4275594</ArticleId><ArticleId IdType="pubmed">25500532</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeda K., Tsutsui H., Yoshimoto T., et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity . 1998;8(3):383&#x2013;390. doi: 10.1016/S1074-7613(00)80543-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1074-7613(00)80543-9</ArticleId><ArticleId IdType="pubmed">9529155</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y.-I., Dallal R. M., Mailliard R. B., Egawa S., Jonak Z. L., Lotze M. T. Interleukin-18 (IL-18) synergizes with IL-2 to enhance cytotoxicity, interferon-gamma production, and expansion of natural killer cells. Cancer Research . 2001;61(3):884&#x2013;888.</Citation><ArticleIdList><ArticleId IdType="pubmed">11221875</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington L. E., Mangan P. R., Weaver C. T. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Current Opinion in Immunology . 2006;18(3):349&#x2013;356. doi: 10.1016/j.coi.2006.03.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2006.03.017</ArticleId><ArticleId IdType="pubmed">16616472</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto T., Tsutsui H., Tominaga K., et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proceedings of the National Academy of Sciences of the United States of America . 1999;96(24):13962&#x2013;13966. doi: 10.1073/pnas.96.24.13962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.24.13962</ArticleId><ArticleId IdType="pmc">PMC24173</ArticleId><ArticleId IdType="pubmed">10570181</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino T., Wiltrout R. H., Young H. A. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. The Journal of Immunology . 1999;162(9):5070&#x2013;5077.</Citation><ArticleIdList><ArticleId IdType="pubmed">10227975</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow J. Y. S., Wong C. K., Cheung P. F. Y., Lam C. W. K. Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cellular &amp; Molecular Immunology . 2010;7(1):26&#x2013;34. doi: 10.1038/cmi.2009.106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2009.106</ArticleId><ArticleId IdType="pmc">PMC4003257</ArticleId><ArticleId IdType="pubmed">20029461</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimoto T., Mizutani H., Tsutsui H., Noben-Trauth N. IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6. Nature Immunology . 2000;1(2):132&#x2013;137. doi: 10.1038/77811.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/77811</ArticleId><ArticleId IdType="pubmed">11248805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa A. S., Elbishbishi E. A., Agarwal R., Chaturvedi U. C. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunology and Medical Microbiology . 2001;30(3):229&#x2013;233. doi: 10.1111/j.1574-695X.2001.tb01575.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-695X.2001.tb01575.x</ArticleId><ArticleId IdType="pubmed">11335143</ArticleId></ArticleIdList></Reference><Reference><Citation>Valero N., Mosquera J., Torres M., et al. Increased serum ferritin and interleukin-18 levels in children with dengue. Brazilian Journal of Microbiology . 2019;50(3):649&#x2013;656. doi: 10.1007/s42770-019-00105-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42770-019-00105-2</ArticleId><ArticleId IdType="pmc">PMC6863311</ArticleId><ArticleId IdType="pubmed">31243722</ArticleId></ArticleIdList></Reference><Reference><Citation>Nanda J. D., Jung C.-J., Satria R. D., et al. Serum IL-18 Is a Potential Biomarker for Predicting Severe Dengue Disease Progression. Journal of Immunology Research. . 2021;2021:1&#x2013;15. doi: 10.1155/2021/7652569.7652569</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/7652569</ArticleId><ArticleId IdType="pmc">PMC8560270</ArticleId><ArticleId IdType="pubmed">34734091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M. F., Chen S. T., Yang A. H., et al. CLEC5A is critical for dengue virus-induced inflammasome activation in human macrophages. Blood . 2013;121(1):95&#x2013;106. doi: 10.1182/blood-2012-05-430090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-05-430090</ArticleId><ArticleId IdType="pubmed">23152543</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C. Y., Liong K. H., Gunalan M. G., et al. Type I IFNs and IL-18 regulate the antiviral response of primary human &#x3b3;&#x3b4; T cells against dendritic cells infected with dengue virus. Journal of Immunology . 2015;194(8):3890&#x2013;3900. doi: 10.4049/jimmunol.1303343.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1303343</ArticleId><ArticleId IdType="pubmed">25732728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zimmer C. L., Cornillet M., Sol&#xe0;-Riera C., et al. NK cells are activated and primed for skin-homing during acute dengue virus infection in humans. Nature Communications . 2019;10(1):p. 3897. doi: 10.1038/s41467-019-11878-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11878-3</ArticleId><ArticleId IdType="pmc">PMC6715742</ArticleId><ArticleId IdType="pubmed">31467285</ArticleId></ArticleIdList></Reference><Reference><Citation>STOP-HCV consortium, van Wilgenburg B., Scherwitzl I., et al. MAIT cells are activated during human viral infections. Nature Communications . 2016;7(1, article 11653) doi: 10.1038/ncomms11653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11653</ArticleId><ArticleId IdType="pmc">PMC4931007</ArticleId><ArticleId IdType="pubmed">27337592</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung J., McQuillan B. M., Chapman C. M. L., Thompson P. L., Beilby J. P. Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology . 2005;25(6):1268&#x2013;1273. doi: 10.1161/01.ATV.0000163843.70369.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.ATV.0000163843.70369.12</ArticleId><ArticleId IdType="pubmed">15790931</ArticleId></ArticleIdList></Reference><Reference><Citation>Tr&#xf8;seid M., Seljeflot I., Arnesen H. The role of interleukin-18 in the metabolic syndrome. Cardiovascular Diabetology . 2010;9(1):p. 11. doi: 10.1186/1475-2840-9-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2840-9-11</ArticleId><ArticleId IdType="pmc">PMC2858122</ArticleId><ArticleId IdType="pubmed">20331890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabkin S. W. The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease. Nature Clinical Practice. Cardiovascular Medicine . 2009;6(3):192&#x2013;199. doi: 10.1038/ncpcardio1453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpcardio1453</ArticleId><ArticleId IdType="pubmed">19234499</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaharieva E., Kamenov Z., Velikova T., Tsakova A., El-Darawish Y., Okamura H. Interleukin-18 serum level is elevated in type 2 diabetes and latent autoimmune diabetes. Endocrine Connections . 2018;7(1):179&#x2013;185. doi: 10.1530/EC-17-0273.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EC-17-0273</ArticleId><ArticleId IdType="pmc">PMC5776671</ArticleId><ArticleId IdType="pubmed">29217651</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhat O., Dhawan V. Role of IL-18 and its signaling in atherosclerosis. Inflammation and Cell Signaling . 2015;2</Citation></Reference><Reference><Citation>Mallat Z., Corbaz A., Scoazec A., et al. Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability. Circulation . 2001;104(14):1598&#x2013;1603. doi: 10.1161/hc3901.096721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/hc3901.096721</ArticleId><ArticleId IdType="pubmed">11581135</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S., Mishra M. K., Ghosh J., Basu A. Japanese Encephalitis Virus infection induces IL-18 and IL-1&#x3b2; in microglia and astrocytes: correlation with in vitro cytokine responsiveness of glial cells and subsequent neuronal death. Journal of Neuroimmunology . 2008;195(1-2):60&#x2013;72. doi: 10.1016/j.jneuroim.2008.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2008.01.009</ArticleId><ArticleId IdType="pubmed">18374991</ArticleId></ArticleIdList></Reference><Reference><Citation>Blom K., Braun M., Pakalniene J., et al. NK cell responses to human tick-borne encephalitis virus infection. Journal of Immunology . 2016;197(7):2762&#x2013;2771. doi: 10.4049/jimmunol.1600950.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1600950</ArticleId><ArticleId IdType="pubmed">27543616</ArticleId></ArticleIdList></Reference><Reference><Citation>Kam Y. W., Leite J. A., Lum F. M., et al. Specific biomarkers associated with neurological complications and congenital central nervous system abnormalities from Zika virus-infected patients in Brazil. The Journal of Infectious Diseases . 2017;216(2):172&#x2013;181. doi: 10.1093/infdis/jix261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix261</ArticleId><ArticleId IdType="pmc">PMC5853428</ArticleId><ArticleId IdType="pubmed">28838147</ArticleId></ArticleIdList></Reference><Reference><Citation>Khaiboullina S. F., Uppal T., Sarkar R., Gorzalski A., St Jeor S., Verma S. C. ZIKV infection regulates inflammasomes pathway for replication in monocytes. Scientific Reports . 2017;7(1):p. 16050. doi: 10.1038/s41598-017-16072-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-16072-3</ArticleId><ArticleId IdType="pmc">PMC5700238</ArticleId><ArticleId IdType="pubmed">29167459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepej S. Z., Mi&#x161;i&#x107;-Majerus L., Jeren T., et al. Chemokines CXCL10 and CXCL11 in the cerebrospinal fluid of patients with tick-borne encephalitis. Acta Neurologica Scandinavica . 2007;115(2):109&#x2013;114. doi: 10.1111/j.1600-0404.2006.00726.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2006.00726.x</ArticleId><ArticleId IdType="pubmed">17212614</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovats S., Turner S., Simmons A., Powe T., Chakravarty E., Alberola-Ila J. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells. Clinical and Experimental Immunology . 2016;186(2):214&#x2013;226. doi: 10.1111/cei.12850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12850</ArticleId><ArticleId IdType="pmc">PMC5054575</ArticleId><ArticleId IdType="pubmed">27513522</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar M., Verma S., Nerurkar V. R. Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death. Journal of Neuroinflammation . 2010;7(1):p. 73. doi: 10.1186/1742-2094-7-73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-73</ArticleId><ArticleId IdType="pmc">PMC2984415</ArticleId><ArticleId IdType="pubmed">21034511</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos H. J., Lanteri M. C., Blahnik G., et al. IL-1&#x3b2; signaling promotes CNS-intrinsic immune control of West Nile virus infection. PLoS Pathogens . 2012;8(11, article e1003039) doi: 10.1371/journal.ppat.1003039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003039</ArticleId><ArticleId IdType="pmc">PMC3510243</ArticleId><ArticleId IdType="pubmed">23209411</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J. L., Niu X. L., Gao Y. L., et al. IL-18 knockout alleviates atopic dermatitis-like skin lesions induced by MC903 in a mouse model. International Journal of Molecular Medicine . 2020;46(2):880&#x2013;888. doi: 10.3892/ijmm.2020.4630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.2020.4630</ArticleId><ArticleId IdType="pubmed">32626950</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaturvedi U. C., Raghupathy R., Pacsa A. S., et al. Shift from a Th1-type response to Th2-type in dengue haemorrhagic fever. Current Science . 1999;76(1):63&#x2013;69.</Citation></Reference><Reference><Citation>Navarro-Gonz&#xe1;lez J. F., Mora-Fern&#xe1;ndez C. The role of inflammatory cytokines in diabetic nephropathy. Journal of the American Society of Nephrology . 2008;19(3):433&#x2013;442. doi: 10.1681/ASN.2007091048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2007091048</ArticleId><ArticleId IdType="pubmed">18256353</ArticleId></ArticleIdList></Reference><Reference><Citation>Dima E., Koltsida O., Katsaounou P., et al. Implication of interleukin (IL)-18 in the pathogenesis of chronic obstructive pulmonary disease (COPD) Cytokine . 2015;74(2):313&#x2013;317. doi: 10.1016/j.cyto.2015.04.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2015.04.008</ArticleId><ArticleId IdType="pubmed">25922275</ArticleId></ArticleIdList></Reference><Reference><Citation>Esmailbeig M., Ghaderi A. Interleukin-18: a regulator of cancer and autoimmune diseases. European Cytokine Network . 2017;28(4):127&#x2013;140. doi: 10.1684/ecn.2018.0401.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/ecn.2018.0401</ArticleId><ArticleId IdType="pubmed">29478963</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma G., Barbieri A., Bimonte S., et al. Interleukin 18: friend or foe in cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer . 2013;1836(2):296&#x2013;303. doi: 10.1016/j.bbcan.2013.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbcan.2013.09.001</ArticleId><ArticleId IdType="pubmed">24120852</ArticleId></ArticleIdList></Reference><Reference><Citation>Park I. H., Yang H. N., Lee K. J., et al. Tumor-derived IL-18 induces PD-1 expression on immunosuppressive NK cells in triple-negative breast cancer. Oncotarget . 2017;8(20):32722&#x2013;32730. doi: 10.18632/oncotarget.16281.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.16281</ArticleId><ArticleId IdType="pmc">PMC5464822</ArticleId><ArticleId IdType="pubmed">28415798</ArticleId></ArticleIdList></Reference><Reference><Citation>Harms R. Z., Yarde D. N., Guinn Z., et al. Increased expression of IL-18 in the serum and islets of type 1 diabetics. Molecular Immunology . 2015;64(2):306&#x2013;312. doi: 10.1016/j.molimm.2014.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molimm.2014.12.012</ArticleId><ArticleId IdType="pmc">PMC4315765</ArticleId><ArticleId IdType="pubmed">25576800</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo E. L., Neves-Souza P. C., Alvarenga A. R., et al. Differential regulation of toll-like receptor-2, toll-like receptor-4, CD16 and human leucocyte antigen-DR on peripheral blood monocytes during mild and severe dengue fever. Immunology . 2010;130(2):202&#x2013;216. doi: 10.1111/j.1365-2567.2009.03224.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2567.2009.03224.x</ArticleId><ArticleId IdType="pmc">PMC2878465</ArticleId><ArticleId IdType="pubmed">20113369</ArticleId></ArticleIdList></Reference><Reference><Citation>Azeredo E. L., Zagne S. M., Alvarenga A. R., Nogueira R. M., Kubelka C. F., de Oliveira-Pinto L. M. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem&#xf3;rias do Instituto Oswaldo Cruz . 2006;101(4):437&#x2013;449. doi: 10.1590/S0074-02762006000400016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0074-02762006000400016</ArticleId><ArticleId IdType="pubmed">16951817</ArticleId></ArticleIdList></Reference><Reference><Citation>Borges M. B., Marchevsky R. S., Carvalho Pereira R., et al. Detection of post-vaccination enhanced dengue virus infection in macaques: an improved model for early assessment of dengue vaccines. PLoS Pathogens . 2019;15(4, article e1007721) doi: 10.1371/journal.ppat.1007721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007721</ArticleId><ArticleId IdType="pmc">PMC6497418</ArticleId><ArticleId IdType="pubmed">31009499</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa V. V., Fagundes C. T., Valad&#xe3;o D. F., et al. A model of DENV-3 infection that recapitulates severe disease and highlights the importance of IFN-&#x3b3; in host resistance to infection. PLoS Neglected Tropical Diseases . 2012;6(5, article e1663) doi: 10.1371/journal.pntd.0001663.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001663</ArticleId><ArticleId IdType="pmc">PMC3362616</ArticleId><ArticleId IdType="pubmed">22666512</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagundes C. T., Costa V. V., Cisalpino D., et al. IFN-&#x3b3; production depends on IL-12 and IL-18 combined action and mediates host resistance to dengue virus infection in a nitric oxide-dependent manner. PLoS Neglected Tropical Diseases . 2011;5(12, article e1449) doi: 10.1371/journal.pntd.0001449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001449</ArticleId><ArticleId IdType="pmc">PMC3243710</ArticleId><ArticleId IdType="pubmed">22206036</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin-Proulx D., Avelino-Silva V. I., Santos B. A. N., et al. MAIT cells are activated in acute dengue virus infection and after in vitro Zika virus infection. PLoS Neglected Tropical Diseases . 2018;12(1, article e0006154) doi: 10.1371/journal.pntd.0006154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006154</ArticleId><ArticleId IdType="pmc">PMC5794195</ArticleId><ArticleId IdType="pubmed">29357366</ArticleId></ArticleIdList></Reference><Reference><Citation>van de Weg C. A., Huits R. M., Pannuti C. S., et al. Hyperferritinaemia in dengue virus infected patients is associated with immune activation and coagulation disturbances. PLoS Neglected Tropical Diseases . 2014;8(10, article e3214) doi: 10.1371/journal.pntd.0003214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003214</ArticleId><ArticleId IdType="pmc">PMC4191960</ArticleId><ArticleId IdType="pubmed">25299654</ArticleId></ArticleIdList></Reference><Reference><Citation>Patra G., Saha B., Mukhopadhyay S. The relationship between changes in IL-2 / IL-18 and liver enzyme with dengue severity. Cytokine . 2021;148:p. 155713. doi: 10.1016/j.cyto.2021.155713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2021.155713</ArticleId><ArticleId IdType="pubmed">34583255</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo A. S., Azhar N. A., Yeow W., et al. Lack of clinical manifestations in asymptomatic dengue infection is attributed to broad down-regulation and selective up-regulation of host defence response genes. PLoS One . 2014;9(4, article e92240) doi: 10.1371/journal.pone.0092240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0092240</ArticleId><ArticleId IdType="pmc">PMC3984081</ArticleId><ArticleId IdType="pubmed">24727912</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiestas Sol&#xf3;rzano V. E., da Costa Faria N. R., dos Santos C. F., et al. Different profiles of cytokines, chemokines and coagulation mediators associated with severity in Brazilian patients infected with dengue virus. Viruses . 2021;13(9):p. 1789. doi: 10.3390/v13091789.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091789</ArticleId><ArticleId IdType="pmc">PMC8473164</ArticleId><ArticleId IdType="pubmed">34578370</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong Y. K., Tan H. Y., Jen S. H., et al. Aberrant monocyte responses predict and characterize dengue virus infection in individuals with severe disease. Journal of Translational Medicine . 2017;15(1):p. 121. doi: 10.1186/s12967-017-1226-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1226-4</ArticleId><ArticleId IdType="pmc">PMC5452397</ArticleId><ArticleId IdType="pubmed">28569153</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran A., Valero N., Mosquera J., Fuenmayor E., Alvarez-Mon M. Gefitinib and pyrrolidine dithiocarbamate decrease viral replication and cytokine production in dengue virus infected human monocyte cultures. Life Sciences . 2017;191:180&#x2013;185. doi: 10.1016/j.lfs.2017.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2017.10.027</ArticleId><ArticleId IdType="pubmed">29055802</ArticleId></ArticleIdList></Reference><Reference><Citation>Duran A., Valero N., Mosquera J., Delgado L., Alvarez-Mon M., Torres M. Role of the myeloid differentiation primary response (MYD88) and TIR-domain- containing adapter-inducing interferon-&#x3b2; (TRIF) pathways in dengue. Life Sciences . 2016;162:33&#x2013;40. doi: 10.1016/j.lfs.2016.08.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2016.08.023</ArticleId><ArticleId IdType="pubmed">27575706</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen C., Yu Y., Gao C., Qi X., Cardona C. J., Xing Z. RIPK3-dependent necroptosis is induced and restricts viral replication in human astrocytes infected with Zika virus. Frontiers in Cellular and Infection Microbiology . 2021;11, article 637710 doi: 10.3389/fcimb.2021.637710.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.637710</ArticleId><ArticleId IdType="pmc">PMC8007970</ArticleId><ArticleId IdType="pubmed">33796483</ArticleId></ArticleIdList></Reference><Reference><Citation>Zmurko J., Marques R. E., Schols D., Verbeken E., Kaptein S. J., Neyts J. The viral polymerase inhibitor 7-deaza-2'-C-methyladenosine is a potent inhibitor of in vitro Zika virus replication and delays disease progression in a robust mouse infection model. PLoS Neglected Tropical Diseases . 2016;10(5, article e0004695) doi: 10.1371/journal.pntd.0004695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0004695</ArticleId><ArticleId IdType="pmc">PMC4862633</ArticleId><ArticleId IdType="pubmed">27163257</ArticleId></ArticleIdList></Reference><Reference><Citation>de Sousa J. R., Azevedo R., Martins Filho A. J., et al. In situ inflammasome activation results in severe damage to the central nervous system in fatal Zika virus microcephaly cases. Cytokine . 2018;111:255&#x2013;264. doi: 10.1016/j.cyto.2018.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.08.008</ArticleId><ArticleId IdType="pubmed">30199767</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaushik D. K., Gupta M., Kumawat K. L., Basu A. NLRP3 inflammasome: key mediator of neuroinflammation in murine Japanese encephalitis. PLoS One . 2012;7(2, article e32270) doi: 10.1371/journal.pone.0032270.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032270</ArticleId><ArticleId IdType="pmc">PMC3290554</ArticleId><ArticleId IdType="pubmed">22393394</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovats S., Turner S., Simmons A., Powe T., Chakravarty E., Alberola-Ila J. West Nile virus-infected human dendritic cells fail to fully activate invariant natural killer T cells. Clinical and Experimental Immunology . 2016;186(2):214&#x2013;226. doi: 10.1111/cei.12850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.12850</ArticleId><ArticleId IdType="pmc">PMC5054575</ArticleId><ArticleId IdType="pubmed">27513522</ArticleId></ArticleIdList></Reference><Reference><Citation>Marquardt N., Ivarsson M. A., Blom K., et al. The human NK cell response to yellow fever virus 17D is primarily governed by NK cell differentiation independently of NK cell education. Journal of Immunology . 2015;195(7):3262&#x2013;3272. doi: 10.4049/jimmunol.1401811.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401811</ArticleId><ArticleId IdType="pubmed">26283480</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>